Peptimatrix
Synthetic peptide hydrogels for 3D cell culture used by pharmaceutical, biotechnology and academic researchers
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-10
About Peptimatrix
PeptiMatrix develops and sells fully synthetic, animal-free peptide hydrogels for 3D cell culture. Its products provide defined, customisable matrix environments with tuneable stiffness and composition for in vitro research.
Customers include pharmaceutical and biotechnology companies and academic researchers. The company sells hydrogel products and offers tailored formulations and pricing for bulk or repeat orders.
PeptiMatrix is a University of Nottingham spinout registered in Nottingham, UK, and was founded in 2023. Its commercial launch was in July 2023; the company received further investment in 2024 and participates in the Mac4Me doctoral network.
Product: A portfolio of synthetic peptide hydrogel products and bespoke formulations for 3D cell culture.
Jobs at Peptimatrix
Leadership
- Cathy Merry · CSO & Co-FounderSource: company website
- John Curd · CEO & Co-FounderSource: company website
More biotech & pharma companies
Peptone
Drug discovery platform designing small-molecule candidates for hard-to-treat cancers and neurodegenerative disease targetsPetagene
Genomic data compression, cloud access and encryption software for genomics researchers and bioinformatics teamsNew on EvolcPfizer
Prescription medicines and vaccines for patients and healthcare professionals in the UKNew on EvolcPheno Therapeutics
Develops GPR17-targeting neuroprotective therapeutics for patients with multiple sclerosis and other neurological disordersNew on EvolcPhlexglobal
ETMF software and trial master file services for pharma, biotech and CRO sponsors running clinical trialsNew on EvolcPhoremost
Biotech developing oral small-molecule cancer drugs, lead programme PMC-001 for primary and metastatic brain cancersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.